Michele Gunsior

1.5k total citations
26 papers, 938 citations indexed

About

Michele Gunsior is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Michele Gunsior has authored 26 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Genetics. Recurrent topics in Michele Gunsior's work include Enzyme Structure and Function (5 papers), Metal-Catalyzed Oxygenation Mechanisms (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Michele Gunsior is often cited by papers focused on Enzyme Structure and Function (5 papers), Metal-Catalyzed Oxygenation Mechanisms (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Michele Gunsior collaborates with scholars based in United States, United Kingdom and Germany. Michele Gunsior's co-authors include Craig A. Townsend, Edward I. Solomon, Jing Zhou, Brian O. Bachmann, Jacques Ravel, Wendy L. Kelly, Elizabeth G. Pavel, Robert Busby, Paul K. Goldsmith and Ronald Wolf and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Michele Gunsior

23 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Gunsior United States 13 616 253 140 137 94 26 938
Zanna Beharry United States 21 736 1.2× 80 0.3× 76 0.5× 175 1.3× 279 3.0× 33 1.3k
T.M. Leissing United Kingdom 10 400 0.6× 121 0.5× 27 0.2× 151 1.1× 50 0.5× 12 607
Caroline Barette France 16 601 1.0× 71 0.3× 37 0.3× 75 0.5× 148 1.6× 40 952
Shanshan Liu China 17 491 0.8× 116 0.5× 101 0.7× 174 1.3× 117 1.2× 39 886
Jimin Shao China 24 1.2k 1.9× 331 1.3× 168 1.2× 456 3.3× 716 7.6× 59 1.9k
Hulai Wei China 18 423 0.7× 59 0.2× 62 0.4× 169 1.2× 243 2.6× 53 834
Lili Chu China 14 309 0.5× 102 0.4× 173 1.2× 72 0.5× 270 2.9× 29 784
Boris Cvek Czechia 12 352 0.6× 108 0.4× 66 0.5× 90 0.7× 311 3.3× 22 842
Ceyda Açılan Türkiye 20 389 0.6× 136 0.5× 61 0.4× 45 0.3× 391 4.2× 46 941
Ganesh Nagaraju India 22 1.1k 1.8× 59 0.2× 53 0.4× 206 1.5× 459 4.9× 36 1.5k

Countries citing papers authored by Michele Gunsior

Since Specialization
Citations

This map shows the geographic impact of Michele Gunsior's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Gunsior with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Gunsior more than expected).

Fields of papers citing papers by Michele Gunsior

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Gunsior. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Gunsior. The network helps show where Michele Gunsior may publish in the future.

Co-authorship network of co-authors of Michele Gunsior

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Gunsior. A scholar is included among the top collaborators of Michele Gunsior based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Gunsior. Michele Gunsior is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lumry, William R., et al.. (2025). Safety and pharmacokinetics of long-acting plasma kallikrein inhibitor navenibart (STAR-0215) in healthy adults. Annals of Allergy Asthma & Immunology. 135(1). 103–111.e2. 2 indexed citations
2.
Gunsior, Michele, Amy S. Rosenberg, Daphne Guinn, et al.. (2025). Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities – a Workshop Report. The AAPS Journal. 27(2). 62–62. 1 indexed citations
3.
Bennett, Jeffrey L., Sean J. Pittock, Friedemann Paul, et al.. (2024). B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity. Annals of Clinical and Translational Neurology. 11(10). 2792–2798. 4 indexed citations
4.
5.
Craig, Timothy, Raffi Tachdjian, Marc A. Riedl, et al.. (2024). STAR-0215 INDUCES RAPID IMPROVEMENTS OF QUALITY OF LIFE IN HAE PATIENTS IN THE ALPHA-STAR TRIAL. Annals of Allergy Asthma & Immunology. 133(6). S26–S26. 1 indexed citations
6.
Morabito, Christopher, Christian V. Stevens, Pradeep Bista, et al.. (2023). Initial Results from a Phase 1 Single Ascending Dose Clinical Trial of STAR-0215, an Investigational Long-Acting Monoclonal Antibody Plasma Kallikrein Inhibitor for Hereditary Angioedema (HAE), in Healthy Subjects Followed for at Least 3 Months. Journal of Allergy and Clinical Immunology. 151(2). AB136–AB136. 3 indexed citations
7.
Aktaş, Orhan, Hans‐Peter Hartung, William A. Rees, et al.. (2023). Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder. Journal of Neurology Neurosurgery & Psychiatry. 94(9). 757–768. 20 indexed citations
8.
Cohen, Ted, Michele Gunsior, Andrew Nichols, et al.. (2023). SUPPORT FOR STAR-0215 ADMINISTERED EVERY THREE- OR SIX-MONTHS FOR HEREDITARY ANGIOEDEMA: PHASE 1A Results:. Annals of Allergy Asthma & Immunology. 131(5). S32–S33. 1 indexed citations
9.
10.
11.
Wolf, Ronald, Christopher Voscopoulos, Paul K. Goldsmith, et al.. (2009). Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer. Cancer Letters. 277(1). 101–107. 31 indexed citations
12.
Lorenzi, Philip L., Michele Gunsior, Laurent Ozbun, et al.. (2008). Asparagine synthetase is a predictive biomarker of l -asparaginase activity in ovarian cancer cell lines. Molecular Cancer Therapeutics. 7(10). 3123–3128. 81 indexed citations
13.
Wolf, Ronald, O. M. Zack Howard, Huifang Dong, et al.. (2008). Chemotactic Activity of S100A7 (Psoriasin) Is Mediated by the Receptor for Advanced Glycation End Products and Potentiates Inflammation with Highly Homologous but Functionally Distinct S100A15. The Journal of Immunology. 181(2). 1499–1506. 141 indexed citations
14.
Lorenzi, Philip L., William C. Reinhold, Martina Rudelius, et al.. (2007). Asparagine synthetase as a causal, predictive biomarker forL-asparaginase activity in ovarian cancer cells. Molecular Cancer Therapeutics. 5(11).
15.
Martin, Scott E., Tamara L. Jones, Cheryl L. Thomas, et al.. (2007). Multiplexing siRNAs to compress RNAi-based screen size in human cells. Nucleic Acids Research. 35(8). e57–e57. 22 indexed citations
16.
Wolf, Ronald, Christopher Voscopoulos, Peter Fitzgerald, et al.. (2006). The Mouse S100A15 Ortholog Parallels Genomic Organization, Structure, Gene Expression, and Protein-Processing Pattern of the Human S100A7/A15 Subfamily During Epidermal Maturation. Journal of Investigative Dermatology. 126(7). 1600–1608. 28 indexed citations
17.
Müller, Ulrike, Friso van Assema, Michele Gunsior, et al.. (2006). Metabolic engineering of the E. coli l-phenylalanine pathway for the production of d-phenylglycine (d-Phg). Metabolic Engineering. 8(3). 196–208. 55 indexed citations
18.
Lorenzi, Philip L., William C. Reinhold, Martina Rudelius, et al.. (2006). Asparagine synthetase as a causal, predictive biomarker for l-asparaginase activity in ovarian cancer cells. Molecular Cancer Therapeutics. 5(11). 2613–2623. 82 indexed citations
19.
Gunsior, Michele, et al.. (2004). The Biosynthetic Gene Cluster for a Monocyclic β-Lactam Antibiotic, Nocardicin A. Chemistry & Biology. 11(7). 927–938. 62 indexed citations
20.
Gunsior, Michele, Jacques Ravel, Gregory L. Challis, & Craig A. Townsend. (2003). Engineeringp-Hydroxyphenylpyruvate Dioxygenase to ap-Hydroxymandelate Synthase and Evidence for the Proposed Benzene Oxide Intermediate in Homogentisate Formation. Biochemistry. 43(3). 663–674. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zanna Beharry Breakdown of academic impact, for papers by T.M. Leissing Breakdown of academic impact, for papers by Caroline Barette Breakdown of academic impact, for papers by Shanshan Liu Breakdown of academic impact, for papers by Jimin Shao Breakdown of academic impact, for papers by Hulai Wei Breakdown of academic impact, for papers by Lili Chu Breakdown of academic impact, for papers by Boris Cvek Breakdown of academic impact, for papers by Ceyda Açılan Breakdown of academic impact, for papers by Ganesh Nagaraju
Rankless by CCL
2026